English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Friday, November 29, 2024
JAL and NEC Test AI-Powered Carry-On Baggage Analysis Solution
Wednesday, November 20, 2024
Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center
Monday, November 18, 2024
World's First Successful Trial of Quantum Tokens Created Using Quantum Technology
富士通など、世界初 スーパーコンピュータ「富岳」を用いてグラフ解析性能200 TeraTEPSを突破
Thursday, November 14, 2024
NEC、量子科学技術研究開発機構および核融合科学研究所から次期スーパーコンピュータシステムを受注
Wednesday, November 13, 2024
Predictive Heart Monitoring Startup, GPx, Secures New Investment From NEC X; Joins Elev X! Boost Venture Studio Program
NEC receives order for next-generation supercomputer system from Japan's National Institutes for Quantum Science and Technology and National Institute for Fusion Science
Tuesday, November 12, 2024
NEC participates in COP29 climate change conference
Friday, November 8, 2024
Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024
Thursday, November 7, 2024
NEC and NEC Bio publish foundational work on T Cell Receptor engineering using proprietary generative AI at the Society for Immunotherapy of Cancer annual meeting
NEC Corporation Links

https://www.facebook.com/nec.global/

https://twitter.com/NEC_corp

https://www.youtube.com/user/NECglobalOfficial

https://www.linkedin.com/company/nec/

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575